We are live on ! Find out more
TCM

Tandem Capital Management Portfolio holdings

AUM $200M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+28.3%
1 Year Est. Return
+25.01%
3 Year Est. Return
+83.81%
5 Year Est. Return
+92.53%
10 Year Est. Return
AUM
$102M
AUM Growth
+$13.3M
Cap. Flow
-$7.58M
Cap. Flow %
-7.43%
Top 10 Hldgs %
34.4%
Holding
77
New
7
Increased
4
Reduced
57
Closed
4

Top Sells

Rank Stock Value
1
KRNT icon
Kornit Digital
KRNT
+$760K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$706K
3
MSFT icon
Microsoft
MSFT
+$705K
4
CGNX icon
Cognex
CGNX
+$700K
5
DAL icon
Delta Air Lines
DAL
+$679K

Sector Composition

Rank Sector Weight
1 Technology 25.44%
2 Healthcare 16.48%
3 Communication Services 14.14%
4 Industrials 13.52%
5 Financials 13.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
76
Vanguard S&P 500 ETF
VOO
$1.01T
-2,270
Closed -$538K
VRTX icon
77
Vertex Pharmaceuticals
VRTX
$123B
-2,965
Closed -$706K

Similar funds

Tandem Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Tandem Capital Management held 77 positions worth $102M, up 15% from $88.8M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tandem Capital Management withdrew a net $7.58M in Q2 2020, closing 4 positions and reducing 57 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $706K position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Tandem Capital Management opened a new position in Verisk Analytics worth $1.59M.

  • Tandem Capital Management's largest Q2 2020 buy was Verisk Analytics: 9,322 shares worth $1.59M.
  • Tandem Capital Management added most to Vanguard Dividend Appreciation ETF in Q2 2020, an estimated $261K increase.
  • Tandem Capital Management's biggest Q2 2020 reduction was Kornit Digital, cutting an estimated $760K.
  • Tandem Capital Management fully exited Vertex Pharmaceuticals in Q2 2020, selling an estimated $706K.
  • Tandem Capital Management's ten largest holdings make up 34% of its $102M portfolio in Q2 2020.
  • Tandem Capital Management opened 7 new positions and closed 4 in Q2 2020.
  • Tandem Capital Management's portfolio value rose 15% quarter-over-quarter to $102M.

Based on Tandem Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.